PainReform (PRFX) News Today $1.39 -0.01 (-0.71%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.37 -0.02 (-1.73%) As of 07/11/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is PainReform Down Today?Toggle Visibility of Why Is PainReform Down Today?PainReform Ltd. (PRFX) announced a strategic investment in LayerBio Inc. to expand its non-opiate pain management pipeline into ophthalmology. While the deal opens a new therapeutic area leveraging LayerBio’s long-acting, non-opiate treatments for eye surgery, investors reacted negatively, driving the stock lower following the announcement. Positive Sentiment: Signed a strategic investment agreement with LayerBio to enter the ophthalmology market and broaden its non-opiate pain portfolio GlobeNewswire Neutral Sentiment: Multiple outlets, including Investing.com, covered the expansion deal details without new financial metrics disclosed Investing.com Negative Sentiment: Shares fell by double digits as the market reacted to potential dilution and execution risks MSN Neutral Sentiment: Reported short interest remains negligible (0 shares, 0.0 days to cover), indicating limited pressure from short sellers as of July 10 Posted 1+ days agoAI Generated. May Contain Errors. PRFX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Painreform stock falls after announcing strategic investment in ...July 11 at 10:44 PM | investing.comPainReform invests in LayerBio to expand into ophthalmologyJuly 11 at 10:44 PM | investing.comPainReform Ltd. enters into a Strategic Investment Agreement to Expand ...July 11 at 10:44 PM | seekingalpha.comPainreform stock falls after announcing strategic investment in LayerBioJuly 10 at 12:09 PM | au.investing.comPainreform Shares Drop 11% After Revealing Strategic Stake in LayerBioJuly 10 at 12:09 PM | msn.comPainReform Expands into Ophthalmology with Strategic Investment in LayerBioJuly 10 at 9:36 AM | tipranks.comPainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain ...July 10 at 9:05 AM | gurufocus.comPainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain ...July 10 at 9:05 AM | gurufocus.comPainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBioJuly 10 at 8:30 AM | globenewswire.comBlade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software SalesMay 27, 2025 | prnewswire.comPainReform Ltd.May 12, 2025 | barrons.comPainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar ProjectsMay 7, 2025 | finance.yahoo.comPainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar ProjectsMay 7, 2025 | globenewswire.comPainReform Regains Nasdaq Compliance as of April 16, 2025April 17, 2025 | tipranks.comPainReform announces expansion into SEM sectorApril 10, 2025 | markets.businessinsider.comPainReform Shareholders Approve Key Proposals at April MeetingApril 10, 2025 | tipranks.comPainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimization MarketApril 10, 2025 | finance.yahoo.comPainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization MarketApril 10, 2025 | globenewswire.comPainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization MarketApril 10, 2025 | globenewswire.comPainReform Ltd: PainReform Provides Year-End Business UpdateApril 8, 2025 | finanznachrichten.dePainReform says shareholder equity now exceeds required thresholdApril 8, 2025 | markets.businessinsider.comPainReform Expands into Clean Energy with DeepSolar AcquisitionApril 7, 2025 | tipranks.comPainReform Provides Year-End Business UpdateApril 7, 2025 | globenewswire.comPainReform’s Shareholder Meeting Adjourned Due to Lack of QuorumApril 3, 2025 | tipranks.comPainReform acquires AI solar analytics firm DeepSolarMarch 7, 2025 | uk.investing.comPainReform Ltd: PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar AnalyticsMarch 5, 2025 | finanznachrichten.dePainReform completes acquisition of DeepSolarMarch 5, 2025 | markets.businessinsider.comPainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar AnalyticsMarch 5, 2025 | globenewswire.comPainReform Ltd. Expands Share Offering to $4 MillionFebruary 26, 2025 | tipranks.comPainReform Ltd: PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion OpportunityFebruary 18, 2025 | finanznachrichten.dePainReform stock soars on DeepSolar acquisitionFebruary 18, 2025 | au.investing.comPainReform enters definitive agreement to acquire DeepSolarFebruary 18, 2025 | markets.businessinsider.comPainReform Diversifies with Acquisition of AI Solar Platform DeepSolarFebruary 18, 2025 | tipranks.comPainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion OpportunityFebruary 18, 2025 | globenewswire.comPainReform Ltd. Gains $3.17 Million from Warrant ExerciseJanuary 2, 2025 | tipranks.comPainReform Phase 3 trial on PRF-110 did not meet primary endpointDecember 28, 2024 | markets.businessinsider.comPainReform Ltd: PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110December 27, 2024 | finanznachrichten.dePainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110December 27, 2024 | globenewswire.comPainReform (NASDAQ:PRFX) Stock Quotes, Forecast and News SummaryDecember 20, 2024 | benzinga.comPainReform Ltd. Navigates Leadership Changes and Nasdaq ComplianceDecember 5, 2024 | markets.businessinsider.comPainReform announces data for PRF-110 Phase 3 trial, notes incoherence of dataNovember 22, 2024 | markets.businessinsider.comPainReform (PRFX) Receives a Hold from Maxim GroupNovember 22, 2024 | markets.businessinsider.comPainReform Ltd: PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical TrialNovember 21, 2024 | finanznachrichten.dePainReform Stock Is Soaring Tuesday: What's Going On?November 21, 2024 | benzinga.comPainReform’s PRF-110 Shows Promise in Initial Trial ResultsNovember 21, 2024 | markets.businessinsider.comPainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical TrialNovember 20, 2024 | globenewswire.comPainReform Announces 1-for-4 Reverse Share SplitNovember 18, 2024 | markets.businessinsider.comPainReform Faces Nasdaq Compliance Challenge Amid Drug DevelopmentNovember 9, 2024 | markets.businessinsider.comPainReform receives noncompliance notification from NasdaqNovember 7, 2024 | markets.businessinsider.comPainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity RequirementNovember 7, 2024 | markets.businessinsider.com Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address PRFX Media Mentions By Week PRFX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRFX News Sentiment▼0.620.99▲Average Medical News Sentiment PRFX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRFX Articles This Week▼101▲PRFX Articles Average Week Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCDA News Today XFOR News Today CSCI News Today PHXM News Today GLYC News Today ADXN News Today APRE News Today TLPH News Today LSB News Today DWTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRFX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainReform Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PainReform With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
